Targeting of Mycobacterium tuberculosis Heparin-Binding Hemagglutinin to Mitochondria in Macrophages
Open Access
- 8 December 2011
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS Pathogens
- Vol. 7 (12) , e1002435
Abstract
Mycobacterium tuberculosis heparin-binding hemagglutinin (HBHA), a virulence factor involved in extrapulmonary dissemination and a strong diagnostic antigen against tuberculosis, is both surface-associated and secreted. The role of HBHA in macrophages during M. tuberculosis infection, however, is less well known. Here, we show that recombinant HBHA produced by Mycobacterium smegmatis effectively induces apoptosis in murine macrophages. DNA fragmentation, nuclear condensation, caspase activation, and poly (ADP-ribose) polymerase cleavage were observed in apoptotic macrophages treated with HBHA. Enhanced reactive oxygen species (ROS) production and Bax activation were essential for HBHA-induced apoptosis, as evidenced by a restoration of the viability of macrophages pretreated with N-acetylcysteine, a potent ROS scavenger, or transfected with Bax siRNA. HBHA is targeted to the mitochondrial compartment of HBHA-treated and M. tuberculosis-infected macrophages. Dissipation of the mitochondrial transmembrane potential (ΔΨm) and depletion of cytochrome c also occurred in both macrophages and isolated mitochondria treated with HBHA. Disruption of HBHA gene led to the restoration of ΔΨm impairment in infected macrophages, resulting in reduced apoptosis. Taken together, our data suggest that HBHA may act as a strong pathogenic factor to cause apoptosis of professional phagocytes infected with M. tuberculosis. Cell death is a common outcome during infection with a number of pathogenic microorganisms. Therefore, defining the factors responsible for killing of host cells is important to uncovering mechanisms of pathogenesis. World-wide, two billon people are latently infected with Mycobacterium tuberculosis, which is still killing 2–3 million people each year. Heparin-binding hemagglutinin (HBHA) protein of M. tuberculosis is known to interact specifically with non-phagocytic cells and to be involved in dissemination from lungs to other tissues. Nevertheless, the role of HBHA in phagocytic cells such as macrophages, which are the first cells of the immune system to encounter inhaled pathogens, has been unknown. In the present study, we suggest HBHA as a critical bacterial protein for macrophage cell death. After M. tuberculosis infection or HBHA treatment of macrophages, HBHA targeted to mitochondria and then caused mitochondrial damage and oxidative stress, which eventually lead to apoptosis. A mutant of M. tuberculosis lacking HBHA induced less apoptosis with moderated mitochondrial damage. These experiments provide a candidate virulence factor which may be a novel target for tuberculosis treatment.Keywords
This publication has 59 references indexed in Scilit:
- Mycobacterium tuberculosis evades macrophage defenses by inhibiting plasma membrane repairNature Immunology, 2009
- Mycobacterium tuberculosis 38‐kDa Lipoprotein is Apoptogenic for Human Monocyte‐derived MacrophagesScandinavian Journal of Immunology, 2008
- Lipid mediators in innate immunity against tuberculosis: opposing roles of PGE2 and LXA4 in the induction of macrophage deathJournal of Experimental Medicine, 2008
- Heparin-Binding-Hemagglutinin-Induced IFN-γ Release as a Diagnostic Tool for Latent TuberculosisPLOS ONE, 2007
- Enhanced priming of adaptive immunity by a proapoptotic mutant of Mycobacterium tuberculosisJournal of Clinical Investigation, 2007
- Mycobacterium tuberculosis nuoG Is a Virulence Gene That Inhibits Apoptosis of Infected Host CellsPLOS Pathogens, 2007
- Apoptosis: A Review of Programmed Cell DeathToxicologic Pathology, 2007
- A Caspase-Independent Pathway Mediates Macrophage Cell Death in Response toMycobacterium tuberculosisInfectionInfection and Immunity, 2007
- Mycobacterium tuberculosis HBHA Protein Reacts Strongly with the Serum Immunoglobulin M of Tuberculosis PatientsClinical and Vaccine Immunology, 2006
- Survival perspectives from the world's most successful pathogen, Mycobacterium tuberculosisNature Immunology, 2003